SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001662579-23-000027
Filing Date
2023-02-10
Accepted
2023-02-10 16:27:22
Documents
1
Period of Report
2023-02-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167606442384071.html 4  
1 FORM 4 wf-form4_167606442384071.xml 4 3046
  Complete submission text file 0001662579-23-000027.txt   4477
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ATARA BIOTHERAPEUTICS, INC. 611 GATEWAY BLVD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address
Koppikar Utpal (Reporting) CIK: 0001742696 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39567 | Film No.: 23612433